このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

受動的脚挙上時のPPVとLVOT VTIの比較による輸液反応性予測

2026年11月3日 更新者:Ahmet Salih Tüzen, MD、Izmir Katip Celebi University

人工呼吸器管理下の重症患者における体液反応性予測における受動的脚挙上操作中の脈圧変動とLVOT VTIに基づく心拍出量変化の比較:前向き観察研究

Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.

The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.

The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.

調査の概要

状態

募集

条件

詳細な説明

This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.

In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.

In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.

Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:

  • Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
  • Non-fluid responsive: Patients showing <10% change in LVOT VTI-based CO following PLR

After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.

The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.

The recorded data will include:

  • Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
  • Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
  • Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database

Informed consent will be obtained from all participating patients or their legally authorized representatives.

研究の種類

観察的

入学 (推定)

48

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Ahmet Salih Tüzen, M.D.
  • 電話番号:+90 535 391 55 77
  • メール:astuzen@icloud.com

研究連絡先のバックアップ

研究場所

      • Izmir、トルコ(Türkiye)
        • 募集
        • Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The study population consists of adult critically ill patients admitted to the Intensive Care Unit (ICU) who are receiving mechanical ventilation support. Eligible participants are those identified by the intensive care team as having a suspected intravascular fluid deficit, for whom a fluid responsiveness assessment is clinically indicated. The cohort specifically targets patients undergoing the Passive Leg Raising (PLR) maneuver as part of routine standard practice, where invasive arterial monitoring is available to record Pulse Pressure Variation (PPV).

説明

Inclusion Criteria:

  1. Adult patients aged ≥18 years
  2. Patients admitted to the intensive care unit receiving mechanical ventilation
  3. Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
  4. Patients in sinus rhythm
  5. Presence of invasive arterial blood pressure monitoring
  6. Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
  7. Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
  8. Hemodynamically stable enough to allow measurement

Exclusion Criteria:

  1. Patients under 18 years of age
  2. Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
  3. Severe right ventricular dysfunction or significant tricuspid regurgitation
  4. Advanced aortic valve disease (severe stenosis or severe regurgitation)
  5. Patients with significant spontaneous breathing effort
  6. Patients receiving lung-protective low tidal volume ventilation strategy (<8 mL/kg) due to ARDS
  7. Inadequate echocardiographic window for LVOT VTI assessment
  8. Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
  9. Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
Fluid Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline.

Fluid Non-Responders

Defined as an increase in LVOT VTI-based Cardiac Output (CO) of < 10% from baseline.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Pulse Pressure Variation (Delta PPV)
時間枠:Baseline (T0) and between 60 seconds after the PLR maneuver.

Pulse Pressure Variation (PPV) is recorded via invasive arterial monitoring at baseline (T0, semi-sitting) and during the Passive Leg Raising maneuver (T1).

Baseline (T0) and between 60 seconds after the PLR maneuver.

二次結果の測定

結果測定
メジャーの説明
時間枠
Percentage Change in Cardiac Output (Delta CO)
時間枠:Baseline (T0) and between 60 seconds after the PLR maneuver.

Cardiac Output (CO) is calculated using the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) and the LVOT diameter measured via transthoracic echocardiography.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Correlation between Delta PPV and Delta CO
時間枠:Baseline (T0) and between 60 seconds after the PLR maneuver.

Correlation Coefficient (r) between PPV Change and Cardiac Output Change

Baseline (T0) and between 60 seconds after the PLR maneuver.
Hemodynamic Parameter Changes (MAP, HR)
時間枠:Baseline (T0) and between 60 seconds after the PLR maneuver.

Measurement of changes in mean arterial pressure and heart rate before and after PLR and comparison between groups.

Baseline (T0) and between 60 seconds after the PLR maneuver.
Diagnostic Accuracy (ROC-AUC, Sensitivity, Specificity, Cut-off)
時間枠:Baseline (T0) and between 60 seconds after the PLR maneuver.

Evaluation of diagnostic performance of ΔPPV and ΔCO using receiver operating characteristic (ROC) analysis, including AUC, optimal cut-off value, sensitivity, and specificity for predicting fluid responsiveness.

Baseline (T0) and between 60 seconds after the PLR maneuver.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Murat Aksun、Izmir Katip Celebi University Atatürk Training and Research Hospital

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年1月1日

一次修了 (推定)

2027年1月1日

研究の完了 (推定)

2027年6月1日

試験登録日

最初に提出

2025年12月13日

QC基準を満たした最初の提出物

2025年12月13日

最初の投稿 (実際)

2025年12月26日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月4日

QC基準を満たした最後の更新が送信されました

2026年11月3日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2025-SAEK-0811

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

IPD プランの説明

All data necessary to support the study protocol, including de-identified individual participant data (IPD) related to study protocol, and primary and secondary outcome measures, will be made available upon reasonable request from qualified researchers for academic purposes, in accordance with institutional and ethical guidelines.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。